Drug resistance
Record details
- ISBN: 9781440839245
- ISBN: 1440839247
- ISBN: 9781440839252
-
Physical Description:
print
xvi, 207 pages ; 23 cm. - Publisher: Santa Barbara, California : Greenwood, an imprint of ABC-CLIO, LLC, [2017]
- Copyright: ©2017
Content descriptions
Bibliography, etc. Note: | Includes bibliographical references and index. |
Formatted Contents Note: | Introduction -- Section I. Overview and historical background of drug resistance. The science of drug resistance -- The role of human behavior in drug resistance -- The scope of the problem today -- Specific diseases -- Measures to combat drug resistance -- Section II. Contemporary issues and debates. Drug resistance as a national and international issue -- Changing physician and pharmacist behavior -- Changing patient behavior -- Balancing individual and societal rights -- Contributions of research to the fight against drug resistance -- Antibiotics in animal husbandry -- Section III. Resources. Primary documents -- Timeline -- Sources for further information. |
Search for related items by subject
Subject: | Drug resistance Antibiotics |
Search for related items by series
Available copies
- 1 of 1 copy available at Kirtland Community College.
Holds
- 0 current holds with 1 total copy.
Show Only Available Copies
Location | Call Number / Copy Notes | Barcode | Shelving Location | Status | Due Date |
---|---|---|---|---|---|
Kirtland Community College Library | QR 177 .B67 2017 | 30775305528631 | General Collection | Available | - |
Drug Resistance
Click an element below to view details:
Table of Contents
Drug Resistance
Section | Section Description | Page Number |
---|---|---|
Series Foreword | p. xi | |
Acknowledgments | p. xiii | |
Introduction | p. xv | |
Section I | Overview and Historical Background of Drug Resistance | p. 1 |
1 | The Science of Drug Resistance | p. 3 |
What Are Antimicrobials? | p. 3 | |
Key Antibiotics in Medical History | p. 7 | |
What Is Antimicrobial Resistance? | p. 13 | |
How Microbes Become Resistant | p. 14 | |
Why Drug Resistance Is a Concern | p. 16 | |
2 | The Role of Human Behavior in Drug Resistance | p. 19 |
Inappropriate Use of Drugs | p. 19 | |
Use of Low-Quality Drugs | p. 23 | |
Use of Antimicrobials in Animal Husbandry | p. 24 | |
3 | The Scope of the Problem Today | p. 25 |
Global Overview of Drug Resistance | p. 25 | |
Drug Resistance in the United States | p. 34 | |
4 | Specific Diseases | p. 43 |
Tuberculosis | p. 43 | |
Gonorrhea | p. 46 | |
Malaria | p. 48 | |
HIV | p. 51 | |
Influenza | p. 53 | |
5 | Measures to Combat Drug Resistance | p. 57 |
National and International Standards of Prescribing Practice | p. 57 | |
Infection Control | p. 65 | |
Vaccination Programs | p. 68 | |
Limiting Disease Spread through Travel | p. 69 | |
Developing New Antibiotics and Improved Diagnostic Tests | p. 72 | |
Surveillance and Reporting Programs | p. 73 | |
Recommendations for Global Surveillance | p. 75 | |
Section II | Contemporary Issues and Debates | p. 77 |
6 | Drug Resistance as a National and International Issue | p. 79 |
Stakeholders | p. 80 | |
Recommendations for Antibiotic Use | p. 81 | |
Developing New Antibiotics | p. 87 | |
7 | Changing Physician and Pharmacist Behavior | p. 95 |
Decision Making in Medicine | p. 96 | |
Physician and Pharmacist Education | p. 97 | |
Health System Guidelines | p. 100 | |
8 | Changing Patient Behavior | p. 103 |
Patient Adherence | p. 103 | |
Obstacles to Adherence | p. 106 | |
Interventions to Improve Adherence | p. 108 | |
9 | Balancing Individual and Societal Rights | p. 111 |
Balancing Infection Control and the Right to Freedom and Privacy | p. 111 | |
DOT | p. 112 | |
Involuntary Quarantine | p. 114 | |
10 | Contributions of Research to the Fight Against Drug Resistance | p. 121 |
The Drug Development Process | p. 121 | |
Antibiotics in the Drug Development Pipeline | p. 125 | |
11 | Antibiotics in Animal Husbandly | p. 127 |
History | p. 129 | |
Specific Threats | p. 130 | |
The Scope of the Issue | p. 132 | |
Balancing Productivity and Public Safety | p. 135 | |
Section III | Resources | p. 139 |
Primary Documents | p. 141 | |
Current Reports | p. 141 | |
Antimicrobial Resistance: Global Report on Surveillance: Summary | p. 141 | |
Antibiotic Resistance Threats in the United States, 2013: Executive Summary | p. 147 | |
Antimicrobial Resistance Surveillance in Europe, 2015: Summary | p. 149 | |
Policy Statements | p. 153 | |
WHO Global Strategy for Containment of Antimicrobial Resistance: Executive Summary | p. 153 | |
National Strategy for Combating Antibiotic Resistance Bacteria: Executive Summary | p. 161 | |
The Judicious Use of Medically Important Antimicrobial Drugs in Food-Producing Animals: Executive Summary | p. 166 | |
Timeline | p. 175 | |
Sources for Further Information | p. 185 | |
Glossary | p. 197 | |
Index | p. 203 |